| Primary |
|
| Cardiac Arrest |
50.0% |
| Dyskinesia |
50.0% |
|
| Secondary |
| Product Used For Unknown Indication |
46.5% |
| Pneumonia |
12.7% |
| Malabsorption |
8.1% |
| Pain |
6.9% |
| Drug Use For Unknown Indication |
2.7% |
| Drug Exposure During Pregnancy |
2.3% |
| Ill-defined Disorder |
2.3% |
| Arterial Disorder |
1.5% |
| Asthma |
1.5% |
| Chemotherapy |
1.5% |
| Diabetes Mellitus |
1.5% |
| Dyslipidaemia |
1.5% |
| Embolism Venous |
1.5% |
| Lung Neoplasm Malignant |
1.5% |
| Prophylaxis Against Transplant Rejection |
1.5% |
| Pruritus |
1.5% |
| Diarrhoea |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Haemorrhage |
1.2% |
| Haemorrhage Prophylaxis |
1.2% |
|
| Wrong Drug Administered |
13.2% |
| Toxic Epidermal Necrolysis |
7.5% |
| Anaphylactic Reaction |
5.7% |
| Diarrhoea |
5.7% |
| Drug Interaction |
5.7% |
| Metabolic Disorder |
5.7% |
| Rash |
5.7% |
| Tonic Convulsion |
5.7% |
| Appetite Disorder |
3.8% |
| Clonic Convulsion |
3.8% |
| Cyanosis |
3.8% |
| Death |
3.8% |
| Gastrointestinal Haemorrhage |
3.8% |
| Haematoma |
3.8% |
| International Normalised Ratio Increased |
3.8% |
| Monoplegia |
3.8% |
| Overdose |
3.8% |
| Pharyngeal Haematoma |
3.8% |
| Premature Baby |
3.8% |
| Vomiting |
3.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
49.3% |
| Drug Use For Unknown Indication |
13.2% |
| Prophylaxis |
6.5% |
| Pain |
3.9% |
| Hypertension |
3.3% |
| Cystic Fibrosis |
2.7% |
| Sepsis |
2.1% |
| Coagulopathy |
1.8% |
| Multiple Myeloma |
1.8% |
| Nausea |
1.7% |
| Diffuse Large B-cell Lymphoma |
1.7% |
| Pyrexia |
1.7% |
| Sedation |
1.6% |
| Supplementation Therapy |
1.6% |
| Depression |
1.4% |
| Constipation |
1.3% |
| Electrolyte Substitution Therapy |
1.3% |
| Thrombocytopenia |
1.3% |
| Medical Diet |
1.1% |
| Angiogram |
1.1% |
|
| Renal Failure |
12.1% |
| Vomiting |
10.1% |
| Weight Decreased |
9.7% |
| Sepsis |
6.5% |
| Thrombocytopenia |
5.7% |
| Pyrexia |
5.3% |
| Renal Failure Acute |
5.3% |
| Pneumonia |
4.9% |
| Febrile Neutropenia |
4.5% |
| Distal Intestinal Obstruction Syndrome |
4.0% |
| Septic Shock |
3.6% |
| Skin Induration |
3.6% |
| Urinary Tract Infection |
3.6% |
| International Normalised Ratio Increased |
3.2% |
| Malaise |
3.2% |
| Wheezing |
3.2% |
| Bradycardia |
2.8% |
| Neutropenia |
2.8% |
| Pseudomembranous Colitis |
2.8% |
| Pulmonary Embolism |
2.8% |
|
| Interacting |
| Product Used For Unknown Indication |
75.0% |
| Pain |
20.0% |
| Bronchitis |
5.0% |
|
| Rash |
33.3% |
| Swelling |
33.3% |
| Blood Urine Present |
16.7% |
| Tendonitis |
16.7% |
|
